Total thyroidectomy does not enhance disease control or survival even in high-risk patients with differentiated thyroid cancer

Annals of Surgery

Volumn 227, Issue 6, 1998, Pages 912-921

  Wanebo, Harold ^a,b   Coburn, Michael ^b   Teates, David ^c   Cole, Bernard ^b  

^a BROWN UNIVERSITY   (United States)

^b ROGER WILLIAMS MEDICAL CENTER   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER CLASSIFICATION; CANCER CONTROL; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLICULAR CARCINOMA; HUMAN; HUMAN TISSUE; LOBECTOMY; MAJOR CLINICAL STUDY; MALE; METASTASIS; PATHOLOGY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SUBTOTAL THYROIDECTOMY; THYROID CANCER; THYROIDECTOMY; TREATMENT INDICATION;

ADULT; AGE FACTORS; AGED; CARCINOMA, PAPILLARY; CARCINOMA, PAPILLARY, FOLLICULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK; RISK FACTORS; SURVIVAL ANALYSIS; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME;

EID: 0032467616     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-199806000-00015     Document Type: Article

References (23)

1. Harness JK, Thompson NW, Burney RE, McLead MK. Total thyroidectomy complications and technique. World J Surg 10:781-786.
2. Clark OH, Duh Q. Thyroid cancer. Med Clin North Am 1991;75: 211-234.
3. Clark OH, Levin K, Zong QI, et al. Thyroid cancer: the case for total thyroidectomy, Eur J Cancer Clin Oncol 1988;21:205-313.
4. Samaan NA, Schultz PN, Hickey RC, et al. The results of various modalities of treatment of well differentiated thyroid carcinoma: a retrospective review of 1599 patients. J Clin Endocrinol Metab 1992; 75:714-720.
5. Cady B, Sedgewick CE, Meissner WA, et al. Changing clinical, pathologic, therapeutic and survival patterns in thyroid carcinoma. Ann Surg 1976;184:541-553.
6. Wanebo HJ, Andrews A, Kaiser DL. Thyroid cancer: some basic considerations. Am J Surg 1981;142:474-479.
7. Beahrs O. Surgical Treatment for thyroid cancer. Br J Surg 1984; 71:976-984.
8. McConahey WM, Hay ID, Woolner LB, et al. Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy and outcome. Mayo Clin Proc 1986;61: 978-996.
9. Hay ID, Grant CS, Taylor WF, McConahey WM. Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 1987;102:1088-1095.
10. Hay ID, Bergstralk EJ, Goelher JR, et al. Predicting outcome in papillary thyroid cancer: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 1993;114:1050-1058
11. Cady B, Rossi R, Silverman M, Wool M. Further evidence of the validity of risk group definition in differentiated thyroid carcinoma. Surgery 1985;98:1171-1178.
12. Shah JP, Loree TR, Dharker D, et al. Prognostic factors in differentiated carcinoma of the thyroid gland. Am J Surg 1992;164:658-661.
13. Bacourt F, Asselain B, Savoie JC, et al. Multifactorial study of prognostic factors in differentiated thyroid carcinoma and a re-evaluation of the importance of age. Br J Surg 1986;73:274-277.
14. Mueller-Gaertner H, Brzac HT, Rehpenning W. Prognostic indices for tumor relapse and tumor mortality in follicular thyroid carcinoma. Cancer 1991;67:1903-1911.
15. Akslen LA, Myking AO, Salvesen H, Varhaug JE. Prognostic importance of various clinicopathological features in papillary thyroid carcinoma. Eur J Cancer 1992;29A:44-51.
16. Coburn MC, Wanebo HJ. Age correlates with increased frequency of high risk factors in elderly patients with thyroid cancer. Am J Surg 1995;170:471-475.
17. Noguchi M, Mizukami Y, Michigishi T, et al. Multivariate study of prognostic factors for differentiated thyroid carcinoma: the significance of histologic subtype. Int Surg 1993;78:10-15.
18. Tennvall J, Biorklund A, Moller T, et al. Is the EORTC prognostic-index of thyroid cancer valid in differentiated thyroid carcinoma? Retrospective multivariate analysis of differentiated thyroid carcinoma with long follow-up. Cancer 1986;57:1405-1414.
19. Akslen LA. Prognostic importance of histologic grading in papillary thyroid carcinoma. Cancer 1993; 721:2680-2685.
20. Anderson PE, Kinsella J, Loree TR et al. Differentiated carcinoma of thyroid with extra thyroidal extension. Am J Surg 1995;170: 467-470.
21. Davis N, Bugis SP, McGregor GI. An evaluation of prognostic scoring systems in patients with follicular thyroid cancer. Am J Surg 1995; 170:476-480.
22. Mazzaferri IL, Jhiang SM. Long term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994;97:418-428.
23. Mazzaferri EL. Treating high thyroglobulin with radioiodine: a magic bullet or a shot in the dark (editorial). J Clin Endocrinol Metab 1995;80:1485-1487.